Brief CBT for the Treatment of Depression During Inpatient Hospitalization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03011619|
Recruitment Status : Recruiting
First Posted : January 5, 2017
Last Update Posted : January 26, 2018
|Condition or disease||Intervention/treatment|
|Depression||Behavioral: Usual Standard of Care Behavioral: Cognitive Behavioral Therapy Condition (CBT)|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Brief CBT for the Treatment of Depression During Inpatient Hospitalization|
|Actual Study Start Date :||April 6, 2017|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
Active Comparator: Control Condition
usual standard of care during an inpatient psychiatric hospitalization; medication management, group therapy, and individual therapy.
Behavioral: Usual Standard of Care
medication management, group therapy, and individual therapy.
Experimental: CBT Condition
If a patient is randomly assigned to the enhanced CBT group, they will participate in manualized CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.
Behavioral: Usual Standard of Care
medication management, group therapy, and individual therapy.Behavioral: Cognitive Behavioral Therapy Condition (CBT)
CBT, including a sequence of sessions that builds upon prior sessions and planned exercises, including worksheets and journal entries.
- Montgomery-Ashberg Depression Scale (MADRS) [ Time Frame: 15 Minutes ]A ten-item clinician-administered questionnaire used to measure the severity of depressive symptoms in patients with mood disorders. The ten questions rate the severity of symptoms on scale of 0 (not present), 2 (mild), 4 (moderate), and 6 (severe). It is designed to be sensitive to change, so is often the scale of choice when interventions, such as psychotherapies, electroconvulsive therapy, or drug trials, are being studied.
- Hamilton Rating Scale for Depression (HAM-D) [ Time Frame: 20 Minutes ]Clinician-administered semi-structured interview with 17 questions. It is designed to measure the severity of depressive symptoms in patients with a primary depressive illness.
- Clinical Global Impression Severity Scale (CGI-S) [ Time Frame: 20 Minutes ]Single-item rating scale of the clinician's assessment of the global severity of depressive symptoms in relation to the clinician's total experience with depressed patients. Severity is rated on a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03011619
|Contact: Yona Silverman||(212) firstname.lastname@example.org|
|Contact: Allison Young||(212) email@example.com|
|United States, New York|
|New York University School of Medicine||Recruiting|
|New York, New York, United States, 10016|
|Contact: Yona Silverman firstname.lastname@example.org|
|Contact: Jacqueline Sergie email@example.com|
|Principal Investigator: Jacqueline Sergie, MD|
|Principal Investigator:||Jacqueline Sergie, MD||NYU School of Medicine|